Akero Therapeutics Ownership | Who Owns Akero Therapeutics?


OverviewForecastFinancialsChart

Akero Therapeutics Ownership Summary


Akero Therapeutics is owned by 105.12% institutional investors, 5.34% insiders. Janus henderson group is the largest institutional shareholder, holding 11.59% of AKRO shares. Vanguard Health Care Inv is the top mutual fund, with 5.77% of its assets in Akero Therapeutics shares.

AKRO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAkero Therapeutics105.12%5.34%-10.46%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Janus henderson group6.88M11.59%$161.28M
Blackrock5.59M9.42%$131.06M
Rtw investments, lp5.43M9.16%$127.43M
Wellington management group llp5.11M8.62%$119.99M
Blackrock funding, inc. /de5.92M8.53%$164.81M
General atlantic5.23M7.54%$145.61M
Price t rowe associates inc /md/4.15M6.99%$97.28M
Vanguard group3.71M6.25%$86.92M
Alkeon capital management3.33M5.61%$78.06M
State street2.69M4.53%$63.09M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
University of wisconsin foundation423.85K11.19%$9.94M
General atlantic5.23M5.18%$145.61M
Propel bio management327.75K4.99%$7.69M
Silverarc capital management625.09K3.46%$14.66M
Yiheng capital management1.43M2.71%$33.65M
Redmile group1.61M2.29%$37.88M
Boxer capital1.68M2.07%$39.34M
Rtw investments, lp5.43M1.97%$127.43M
Logos global management lp800.00K1.51%$18.77M
Bioimpact capital385.99K1.41%$9.06M

Top Buyers

HolderShares% AssetsChange
Janus henderson group6.88M0.09%754.28K
Blackrock5.59M0.00%694.02K
T. rowe price investment management1.77M0.03%665.19K
Morgan stanley946.53K0.00%542.66K
Long focus capital management719.60K0.65%391.00K

Top Sellers

HolderShares% AssetsChange
Baker bros. advisors lp1.10M0.33%-1.62M
Fred alger management123.79K0.01%-1.21M
State street2.69M0.00%-1.11M
Braidwell lp---1.08M
Artisan partners limited partnership---303.92K

New Positions

HolderShares% AssetsChangeValue
Great lakes advisors193.38K0.05%193.38K$5.38M
Corebridge financial36.47K0.00%36.47K$855.66K
Mirae asset global etfs35.47K0.00%35.47K$831.83K
Trexquant investment lp24.65K0.01%24.65K$578.31K
Two sigma advisers, lp18.10K0.00%18.10K$424.63K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-12.00
Riggs asset managment-14.00
Capital performance advisors llp-20.00
Ica group wealth management-110.00
Pacer advisors-688.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202418014.65%72,997,3861.71%1050.72%858.97%577.55%
Jun 30, 2024157-15.14%71,768,872-1.77%1210.80%78-29.09%5312.77%
Mar 31, 20241858.82%73,065,46123.85%1231.10%11025.00%47-2.08%
Dec 31, 2023170-21.30%58,992,8463.30%1051.00%88-29.60%4829.73%
Sep 30, 202321622.03%57,109,1940.85%1020.86%12526.26%37-5.13%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Health Care Inv4.40M5.77%-
Vanguard Total Stock Mkt Idx Inv1.94M2.78%20.95K
T. Rowe Price New Horizons1.78M2.55%-
US Small-Cap Growth II Equity Comp1.78M2.55%-33.35K
iShares Russell 2000 ETF1.84M2.41%-14.00K
Janus Henderson Global Life Sciences D1.67M2.39%-122.47K
Janus Henderson Global Life Sciences1.64M2.15%-378.12K
Janus Henderson Glb Life Scn I2 USD1.30M1.71%-16.78K
Janus Global Life Science AUSD1.30M1.71%-193.92K
Vanguard Institutional Extnd Mkt Idx Tr954.54K1.37%-6.36K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 30, 2025Graham G. Walmsley-Buy$9.60M
Feb 05, 2025Rolph Timothy Chief Scientific OfficerSell$336.02K
Feb 05, 2025Rolph Timothy Chief Scientific OfficerSell$723.61K
Feb 03, 2025Young Jonathan Chief Operating OfficerSell$273.18K
Feb 03, 2025Young Jonathan Chief Operating OfficerSell$264.88K

Insider Transactions Trends


DateBuySell
2025 Q1118
2024 Q4-31
2024 Q3-26
2024 Q2-10
2024 Q1-12

AKRO Ownership FAQ


Who Owns Akero Therapeutics?

Akero Therapeutics shareholders are primarily institutional investors at 105.12%, followed by 5.34% insiders and -10.46% retail investors. The average institutional ownership in Akero Therapeutics's industry, Biotech Stocks , is 109.70%, which Akero Therapeutics falls below.

Who owns the most shares of Akero Therapeutics?

Akero Therapeutics’s largest shareholders are Janus henderson group (6.88M shares, 11.59%), Blackrock (5.59M shares, 9.42%), and Rtw investments, lp (5.43M shares, 9.16%). Together, they hold 30.17% of Akero Therapeutics’s total shares outstanding.

Does Blackrock own Akero Therapeutics?

Yes, BlackRock owns 9.42% of Akero Therapeutics, totaling 5.59M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 131.06M$. In the last quarter, BlackRock increased its holdings by 694.02K shares, a 14.19% change.

Who is Akero Therapeutics’s biggest shareholder by percentage of total assets invested?

University of wisconsin foundation is Akero Therapeutics’s biggest shareholder by percentage of total assets invested, with 11.19% of its assets in 423.85K Akero Therapeutics shares, valued at 9.94M$.

Who is the top mutual fund holder of Akero Therapeutics shares?

Vanguard Health Care Inv is the top mutual fund holder of Akero Therapeutics shares, with 5.77% of its total shares outstanding invested in 4.4M Akero Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools